Outcome after thyroid surgery for metastasis from renal cell cancer

被引:20
|
作者
Machens, Andreas [1 ]
Dralle, Henning [1 ]
机构
[1] Univ Halle Wittenberg, Dept Gen Visceral & Vasc Surg, D-06097 Halle, Germany
关键词
LYMPH-NODE METASTASIS; VENA-CAVA; CARCINOMA; GLAND;
D O I
10.1016/j.surg.2009.08.015
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Owing to their rarity, the Prognostic ramifications of thyroid metastases from renal cell cancer are unclear. Methods. This retrospective analysis comprised 17 patients who underwent thyroid surgery (15 total thyroidectomies, 2 lobectomies) for renal cell cancer metastases. Results. The mean follow-up after thyroid surgery was 65 months. Seven of the 9 deaths involved patients with extrathyroidal metastatic growth despite previous locally curative resection in all but I patient. There was a strong relationship between extrathyroidal growth and recurrent laryngeal nerve invasion (57 vs 0%; P = .015), cervical lymph node metastasis (71 vs 0%; P = .003), the number of positive neck nodes (means of 1 vs 0 nodes; P = .0.14), laryngeal, tracheal or esophageal invasion (43 vs 0%; P = .05), and internal jugular vein invasion (43 vs 0%; P = .05). Powerful effects on cause-specific mortality after thyroid operation for renal cell cancer metastases were seen fir extrathyroidal growth (means of 15 vs 69 months; P = .004) and recurrent laryngeal nerve invasion (means of 10 vs 56 months; P = .002). Conclusion. Extrathyroidal metastatic growth reflects an aggressive tumor biology, which may extend to other-renal cell cancer metastases outside the neck. In. this setting, extensive surgery aimed at preventing local complications should be embedded in a systemic treatment concept. (Surgery 2010;147:65-71.)
引用
收藏
页码:65 / 71
页数:7
相关论文
共 50 条
  • [1] Surgical Outcome for Pancreatic Metastasis From Renal Cell Cancer
    Matsunaga, Y.
    Higuchi, R.
    Yazawa, T.
    Uemura, S.
    Izumo, W.
    Akao, J.
    Shiihara, M.
    Nagano, E.
    Yamamoto, M.
    PANCREAS, 2019, 48 (10) : 1488 - 1488
  • [2] Metastasis from renal cell carcinoma to the thyroid 12 years after nephrectomy
    Chin, Christopher J.
    Franklin, Jason H.
    Moussa, Madeleine
    Chin, Joseph L.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (12) : 1398 - 1399
  • [3] Thyroid Metastasis From Primary Renal Cell Cancer on FDG PET/CT
    Kaushik, Aarti
    Ho, Linh
    CLINICAL NUCLEAR MEDICINE, 2011, 36 (01) : 56 - 58
  • [4] RENAL CANCER AND THYROID METASTASIS
    GILLOZ, A
    PREYNAT, P
    JOURNAL D UROLOGIE ET DE NEPHROLOGIE, 1973, 79 (12BI): : 413 - 415
  • [5] Isolated thyroid metastasis from renal cell carcinoma
    Kim, Ah-Young
    Park, Sung Bin
    Choi, Hee Seok
    Hwang, Jae Cheol
    JOURNAL OF ULTRASOUND IN MEDICINE, 2007, 26 (12) : 1799 - 1802
  • [6] Thyroid metastasis from clear cell renal carcinoma
    de la Fuente Bartolome, Marta
    Osorio Silla, Irene
    Gutierrez Samaniego, Maria
    Martinez Pueyo, Jose Ignacio
    de la Cruz Vigo, Felipe
    ENDOCRINOLOGIA Y NUTRICION, 2014, 61 (05): : 296 - 297
  • [7] Metastasis of liver cancer to the thyroid after surgery: A case report
    Hao-Chen Zhong
    Zhao-Wei Sun
    Guang-Hua Cao
    Wei Zhao
    Kai Ma
    Bing-Yuan Zhang
    Yu-Jie Feng
    World Journal of Clinical Cases, 2022, 10 (15) : 5036 - 5041
  • [8] Metastasis of liver cancer to the thyroid after surgery: A case report
    Zhong, Hao-Chen
    Sun, Zhao-Wei
    Cao, Guang-Hua
    Zhao, Wei
    Ma, Kai
    Zhang, Bing-Yuan
    Feng, Yu-Jie
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (15) : 5036 - 5041
  • [9] Late onset of metastasis after surgery for renal cell cancer prefers unusual locations
    Lipsky, K
    Zigeuner, RE
    Rehak, P
    Schips, L
    Langner, C
    JOURNAL OF UROLOGY, 2006, 175 (04): : 362 - 362
  • [10] Reoperation after surgery for bone metastasis of renal cell carcinoma
    Tsukamoto, Shinji
    Aiba, Hisaki
    Zuccheri, Federica
    Mavrogenis, Andreas F.
    Kido, Akira
    Honoki, Kanya
    Tanaka, Yasuhito
    Donati, Davide Maria
    Errani, Costantino
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (03) : 629 - 640